Save the Children UK

Aplos Software | June 20, 2020

In just 30 days, more than $30,000 in discounts have been given to nonprofits and churches in the wake of COVID-19 to enable them to get the software and digital tools they need to resume their operations in the weeks and months ahead. Aplos has been practically giving away their software platform, with the option of adding mobile giving and communications features, in an effort to help nonprofits and churches operate remotely while sheltering in place due to the coronavirus. Traditional ways th...

Nonprofit Management

Blue Cross Blue Shield of Arizona | November 09, 2020

Blue Cross© Blue Shield© of Arizona (BCBSAZ) is inviting Arizonans to nominate a local hero who has gone above and beyond to help others during the COVID-19 pandemic. From first responders and health care workers to grocery store clerks and teachers, BCBSAZ will recognize 30 Arizonans with a $1,000 prize as a gesture of gratitude for stepping up to serve others in a time of uncertainty and disruption....

Financial Management, Philanthropy

Globenewswire | August 21, 2023

GuideOne Foundation (“Foundation”), the philanthropic arm of GuideOne Insurance, announced today that it distributed community grants totaling $37,000 to 34 charities. The grants, which are one component of the Foundation’s 2023 giving efforts, are awarded by the Foundation’s Employee Advisory Committee to provide financial assistance to charitable organizations that positively develop, enhance and impact the communities where GuideOne employees live and work. ...

Fundraising

Lung Cancer Research Foundation | February 01, 2022

The Lung Cancer Research Foundation (LCRF) and KRAS Kickers are excited to announce a partnership aimed at raising much needed funds for research. Together they to pledge to fund at least one two-year grant in 2022 with the goal of improving outcomes for people with KRAS-mutant lung cancer. KRAS is the most common mutation in non-small cell lung cancer patients, making up about 30% of driver mutations in lung adenocarcinoma. KRAS was considered undruggable until last year's FD...